Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1731 of 6351
-
Can a malaria drug help sarcoidosis patients ditch steroids?
Disease control Recruiting nowSarcoidosis is a systemic granulomatous disease of unknown aetiology, mainly affecting the lungs and lymphatics. It affects people worldwide (incidence, 4.7-64/100000; prevalence, 1-36/100000/year). Although it is most often a benign acute or subacute condition, sarcoidosis may p…
Phase 4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 17:09 UTC
-
Real-world MS drug study tracks relapse reduction in italian patients
Disease control OngoingStudy to evaluate the effectiveness of ofatumumab in Italian RRMS patients in the real-life setting.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New targeted radiation approach tackles Hard-to-Treat prostate cancer
Disease control OngoingThe purpose of this study is to evaluate the change in the expression of treatment targets on the surface of tumor cells (Prostate Specific Membrane Antigen (PSMA), Somatostatin Receptor 2 (SSTR2), and Gastrin Releasing Peptide Receptor (GRPR) between the baseline and following t…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can corneal transplant patients ditch steroids after one year?
Disease control Recruiting nowRationale: The cornea is the most transplanted tissue in the Netherlands, with more than 1,500 procedures performed each year. A minimally invasive technique called Descemet Membrane Endothelial Keratoplasty (DMEK) has become the preferred method in the past decade. The main adv…
Phase 4 • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Telehealth program aims to boost quality of life for veterans with lung and sleep disorders
Symptom relief Recruiting nowThe investigators will conduct a Type I hybrid effectiveness-implementation study to test an integrated telehealth intervention among 400 overweight and obese patients with Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA). The investigators will incl…
Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New CAR t cell therapy takes on Hard-to-Treat ovarian cancer
Disease control Recruiting nowThe purpose of this study is to test the safety and tolerability of using a new treatment called autologous T lymphocyte chimeric antigen receptor cells against the B7-H3 antigen (iC9-CAR.B7-H3 T cells) in patients with ovarian cancer that came back after receiving standard thera…
Phase 1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Stroke drug timing could boost recovery, study finds
Symptom relief CompletedThis study is a prospective, multicenter, randomized, open-label, blinded-endpoint trial designed to evaluate the difference in efficacy of Butylphthalide Sodium Chloride Injection treatment initiated early (\<3 hours) versus late (3-6 hours) in patients with acute ischemic st…
Phase 2 • Sponsor: Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New drug shows promise in shrinking fatty liver
Disease control CompletedThis study will evaluate the effect of efinopegdutide administration once every 2 weeks (Q2W) versus once weekly (Q1W) on mean relative reduction from baseline in liver fat content (LFC) after 28 weeks, as well as the safety and tolerability of the different regimens of efinopegd…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Rapid STI test aims to curb antibiotic misuse
Diagnosis CompletedThis study is designed to assess the comparative clinical utility of the point of care cobas® liat CT/NG/MG to current standard practices in the diagnosis and treatment of urogenital infections with Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Mycoplasma genitalium…
Sponsor: Hoffmann-La Roche • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Your phone could predict your fall risk: a new app aims to keep seniors safe
Knowledge-focused Recruiting nowCreation and use of a smartphone application for older adults to assess the participants' risk of fall. Phase 1: Compare the accuracy and validity of accelerometer and gyroscopic data from a smartphone and gold-standard, wearable sensors gathered during balance and gait activitie…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Could a sweet syrup replace the unpleasant colonoscopy prep?
Disease control CompletedThis study compared two different ways to clean the bowel before a colonoscopy: lactulose (a sweet syrup mixed with water) versus high-volume polyethylene glycol (PEG, the usual standard treatment). The goal was to find out which one cleans the bowel better, is easier for patient…
Sponsor: National Institute of Medical Sciences and Nutrition, Salvador Zubiran • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
CBD vs. weed: can hemp help heavy users quit?
Disease control Recruiting nowThis study is a placebo-controlled randomized trial comparing the effects of hemp-derived cannabidiol (CBD) with and without Delta-9-tetrahydrocannabinol (THC), relative to placebo, on reducing cannabis use and cannabis use disorder (CUD) symptoms in adult treatment seeking canna…
Phase 2 • Sponsor: University of Colorado, Boulder • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New gel could shield breast cancer patients from radiation burns
Prevention OngoingThis clinical trial is testing a new skin gel called GR1014-CG to evaluate its safety and see if it can help prevent or reduce skin irritation (such as redness, soreness, etc.) caused by radiation therapy (RT) after breast-conserving surgery for early-stage breast cancer. The stu…
Phase 2 • Sponsor: Graegis Pharmaceuticals Ltd • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
New drug combo aims to boost growth in kids with dwarfism
Disease control OngoingThis proof-of-concept trial is being conducted to evaluate the efficacy, safety and tolerability of combination treatment with navepegritide and lonapegsomatropin administered as separate subcutaneous (SC) injections once weekly in children with achondroplasia (ACH) aged 2 to 11 …
Phase 2 • Sponsor: Ascendis Pharma Growth Disorders A/S • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New asthma drug shows promise in Mid-Stage trial
Disease control OngoingPhase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma.
Phase 2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
HPV vaccine push in schools could cut cancer risk for south african kids
Prevention PausedHuman Papillomavirus (HPV) is the most common sexually transmitted infection globally, and is causally linked to cervical, anogenital, and oropharyngeal cancers. HPV-associated cancers have a disproportionate impact in low-resource settings and nowhere is this evident than in Sou…
Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
A new program aims to ease cancer survivors' fear of recurrence
Symptom relief Recruiting nowThe purpose of this study is to evaluate the process and outcomes of an implementation program designed to implement fear of cancer screening, referral and management into routine cancer care clinics, using a stepped-wedge cluster randomized controlled trial.
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Heart rhythm showdown: ablation vs. electric shock for AF
Disease control Recruiting nowThe main aim of the research is to investigate whether patients undergoing pulmonary vein isolation with catheter ablation for persistent atrial fibrillation (AF) will have lower rates of AF recurrence than those treated by DC cardioversion without an ablation procedure.
Sponsor: Barts & The London NHS Trust • Aim: Disease control
Last updated Jun 26, 2026 12:54 UTC
-
New pill AC-003 tested for severe transplant complication
Disease control Recruiting nowThe study was an open-label, single-arm, dose-escalation, Phase Ib, multi-center study to investigate safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of AC-003 in patients with grade II-IV SR-aGVHD.
Phase 1 • Sponsor: Accro Bioscience (Suzhou) Limited • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New zap-and-heal catheter aims to fix irregular heartbeat without long-term drugs
Disease control Recruiting nowThe objective of this study is to demonstrate initial safety and effectiveness of the CellFX nano-second Pulsed Field Ablation (nsPFA or nano-PFA) 360 Catheter Endocardial Ablation System in treating subjects with atrial fibrillation.
Sponsor: Pulse Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC